Long acting expertise Innocore specializes in formulation, process development, and manufacturing of long acting injectable drug delivery products for peptides, biologics, and small molecules, indicating a strong value proposition for partners seeking extended dosing and improved patient adherence.

Biodegradable polymer platform Leveraging the SynBiosys biodegradable polymer technologies enables customizable, sustained release from days to six months, precise particle size control, and compatibility with small needle injections, presenting clear collaboration avenues for API stability and patient-friendly delivery.

Partnership model The combination of developmental collaborations and licensing partnerships suggests opportunities for co-development deals, technology licensing, and embedded manufacturing capacity for clients aiming to accelerate time-to-market of long-acting injectables.

Market engagement Active presence at major life science events (NLSDays, BIO International, DDF Summit, Swiss Biotech Day, Bio-Europe Spring) signals readiness to partner with sponsors, pharma, and biotech companies seeking strategic alliances and business development engagements.

Growth signals Current revenue range and mid-sized employee base, along with a clear focus on biotech and peptide/biologic therapeutics, indicate scalable collaboration potential with larger CROs/pharma companies seeking specialized manufacturing and delivery solutions for complex APIs.